Latest Publications

Share:

Biologics and Biosimilars Landscape: IP, Policy, and Market Developments

In this review, we discuss the most important recent developments in the biosimilars space, including new biosimilar approvals and launches, litigation under the Biologics Price Competition and Innovation Act (BPCIA),...more

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

On December 7, the Biden administration announced a proposed framework for determining whether the government may exercise its march-in rights to license pharmaceutical patents to third parties if it determines that the price...more

Texas Patent Litigation Monthly Wrap-Up - July 2022

​​​​​​​This post reviews three July 2022 opinions from the Western and Eastern Districts of Texas resolving motions to stay. The first case involves the denial of a stay pending reexamination proceedings issued by the...more

EDTX Monthly Wrap-Up — April 2021

This post reviews two April 2021 opinions from the Eastern District of Texas deciding post-trial motions. The first case involves the denial of enhanced damages by the Honorable Amos L. Mazzant, III. In the second case, the...more

EDTX Monthly Wrap-Up – March 2020

This post analyzes three March 2020 opinions from the Eastern District of Texas deciding motions to stay pending: (1) an IPR filed by a third party; (2) a declaratory judgment action pursuant to the customer-suit exception;...more

EDTX & NDTX Monthly Wrap-Up – April 2019

A Tale of Two ANDAs: Jurisdiction and Venue in a Non-Traditional Sense - Judge Gilstrap’s recent opinion in Apicore US LLC v. Beloteca, Inc., No. 2:19-CV-00077-JRG, 2019 WL 1746079 (E.D. Tex. Apr. 18, 2019), highlights...more

EDTX & NDTX Monthly Wrap-Up — April 2018

This post is our latest review of noteworthy case developments in the Eastern and Northern Districts of Texas for the month of April 2018. Two subjects stand out this month from the Eastern District: (1) testimony of damages...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide